Sie verwenden einen veralteten Browser. Bitte aktualisieren Sie Ihren Browser damit die Seite verwendet werden kann.
Benefits of our 3D technology
It is possible to produce up to 5 million industrial components or up to 200 million tablets with flexibly designable delivery profiles for the active pharmaceutical ingredients every year with just one of our 3D systems.
That is large-scale production at its best.
It is possible to easily process ceramics, metals and polymers as well as active pharmaceutical ingredients and biomaterials like active cell cultures and flexibly combine them with each other.
Resolutions of up to 30,000 dpi make it possible to manufacture ultra-fine structures with wall thicknesses of less than 50 micrometers. And do so with consistently high quality in large-scale production.
Only a few companies can do that. But it is a matter of course for us.
Compared to traditional manufacturing technologies, we are able to produce the screens that are required to use our 3D technology within just 24 hours. There is no need for time-consuming and cost-intensive tool and mold construction.
And it only takes only a few minutes to switch from one component or one material to another.
Our 3D technology is based on an energy-efficient and environmentally friendly cold printing process. At room temperature, without the need for any lasers.
This protects the materials used and ensures that the processed biomaterial can survive. That is all part of the package!
The high precision of our 3D technology eliminates the need for time-consuming and costly post-processing for the manufactured components. No depowdering is required.
Dr. Gereon Heinemann
Chief Executive Officer
+41 56 484 55 31
Dr. Srdan Vasic
Chief Sales Officer
+41 56 484 55 38
Dr. Michael Cloots
Chief Technology Officer
+41 44 520 45 94